MediciNova Inc (MNOV)
1.47
+0.11
(+8.09%)
USD |
NASDAQ |
Mar 27, 16:00
1.41
-0.06
(-4.08%)
Pre-Market: 09:28
MediciNova Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2021 | 20.78M |
September 30, 2021 | 21.10M |
June 30, 2021 | 25.98M |
March 31, 2021 | 26.79M |
December 31, 2020 | 7.106M |
September 30, 2020 | 10.08M |
June 30, 2020 | 8.126M |
March 31, 2020 | 7.105M |
December 31, 2019 | 10.62M |
September 30, 2019 | 8.800M |
June 30, 2019 | 5.640M |
March 31, 2019 | 7.703M |
December 31, 2018 | 42.81M |
September 30, 2018 | 45.80M |
June 30, 2018 | 49.35M |
March 31, 2018 | 49.77M |
December 31, 2017 | 10.80M |
September 30, 2017 | 6.530M |
June 30, 2017 | 2.979M |
March 31, 2017 | 0.7555M |
December 31, 2016 | 8.666M |
September 30, 2016 | 8.412M |
June 30, 2016 | 24.60M |
March 31, 2016 | 24.90M |
December 31, 2015 | 17.56M |
Date | Value |
---|---|
September 30, 2015 | 18.35M |
June 30, 2015 | 2.182M |
March 31, 2015 | 1.482M |
December 31, 2014 | 4.162M |
September 30, 2014 | 3.464M |
June 30, 2014 | 3.965M |
March 31, 2014 | 15.05M |
December 31, 2013 | 13.37M |
September 30, 2013 | 13.75M |
June 30, 2013 | 14.14M |
March 31, 2013 | 3.153M |
December 31, 2012 | 1.545M |
September 30, 2012 | 8.400M |
June 30, 2012 | 7.267M |
March 31, 2012 | -6.907M |
December 31, 2011 | 0.1557M |
September 30, 2011 | -7.075M |
June 30, 2011 | -8.788M |
March 31, 2011 | 7.607M |
December 31, 2010 | -0.9266M |
September 30, 2010 | -0.9677M |
June 30, 2010 | 1.108M |
March 31, 2010 | -1.449M |
December 31, 2009 | 18.09M |
September 30, 2009 | 18.06M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
5.640M
Minimum
Jun 2019
26.79M
Maximum
Mar 2021
13.32M
Average
9.439M
Median
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 4.971M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | -1.206M |
Ampio Pharmaceuticals Inc | 0.00 |